
PROJECTS
Cardiac ischemia reperfusion injury
Our continuing studies on cardiac tissue have
direct implications for the reversible
(arrhythmias and stunning) and irreversible
(necrosis/apoptosis) damage that occurs during
myocardial ischemia/reperfusion (IR) injury. In
this regard, it is a current focus of my
laboratory’s research program to provide
important new information on the cellular ionic
events that occur during IR injury and identify
mechanisms that may be harnessed to reduce
myocardial damage. Specifically we are studying
the roles of ATP-sensitive potassium channels and
sodium/calcium exchangers (NCX1) in the etiology
of IR injury, cardiac surgery and
transplantation. (research funded by operating
grants from the CIHR).
Molecular biology of NCX1
splice variants
Molecular biology of NCX1
splice variantsIslet signalling and diabetes
Another aspect of our research program is the
study of the ionic events that control insulin
secretion and how dysfunction can lead to
impaired/incorrect insulin secretion contributing
to the development of type II diabetes. In
pancreatic beta-cells, hormonal and metabolic
control of ion channel and exchanger function is
crucial in transducing the correct insulin
secretory response. We are studying the links
between common genetic variations in the
ATP-sensitive potassium channel in relation to
fat metabolism. See how KATP channels control
insulin secretion.
Single channel recording of KATP channels
Molecular biology of the KATP channel
We are also investigating the potential for development of novel "glucose-sensitive" therapeutic agents that target ion transport processes within the beta-cell.
(funded by operating grants from the CDA and the CIHR)
Our lab is a member of the islet signalling group within the Alberta Diabetes Institute.
Single channel recording of KATP channels
Molecular biology of the KATP channel
We are also investigating the potential for development of novel "glucose-sensitive" therapeutic agents that target ion transport processes within the beta-cell.
(funded by operating grants from the CDA and the CIHR)
Our lab is a member of the islet signalling group within the Alberta Diabetes Institute.
Islet engineering
The "Edmonton
protocol" has now become the gold standard for
islet transplantation. However, there is still a
clear need to improve both the longevity and
function of the islet grafts. My lab is using
molecular and gene delivery techniques in
the in
vitro
donor islets to facilitate islet graft survival
and insulin secretory capacity.
(funded by a
pilot grant from the ADI and
JDRF)



